Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-9.58	59.97	66.32
Graham Fair Price	-29.50	26.44	37.51
PEG	-173.61	-3.33	-1.22
Price/Book	-11.72	2.33	2.64
Price/Cash Flow	37.18	144.60	105.41
Prices/Earnings	82.11	171.54	94.19
Price/Sales	-6.11	14.22	15.14
Price/FCF	37.18	144.60	105.41
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.17	0.56	0.56
Operating Margin	72.98	0.18	0.11
ROA	-50.49	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-51.53
ROIC	< 0.005	-0.01	96.70
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.10	68.25
Dividends QOQ	< 0.005	< 0.005	-64.47
EBIT QOQ	-0.40	0.65	61.90
EPS QOQ	-0.77	-0.52	33.44
FCF QOQ	-0.37	-0.35	6.75
Revenue QOQ	0.04	-0.05	26.37
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	164.56	175.65	6.74
Days Sales Outstanding (DSO)	51.57	54.71	6.09
Inventory Turnover	0.55	0.51	-6.31
Debt/Capitalization	0.30	0.28	-7.17
Quick Ratio	1.13	1.23	9.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	94.49	95.67	1.26
Cash	5.10	5.45	6.76
Capex	-0.59	-0.82	-38.68
Free Cash Flow	2.37	1.54	-34.84
Revenue	16.47	15.68	-4.79
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.32	2.51	8.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.42	8.04	-4.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating